Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2

Interventions

pembrolizumab 244Nivolumab 140Cisplatin 135Cyclophosphamide 134Paclitaxel 113Carboplatin 108Gemcitabine 98Radiotherapy 83Dexamethasone 83Docetaxel 77atezolizumab 68Ipilimumab 68Doxorubicin 62Fluorouracil 60Blood Specimen Collection 58Bevacizumab 58fludarabine 54Rituximab 54Etoposide 53Oxaliplatin 52Surveys and Questionnaires 49Lenalidomide 49Prednisone 47Standard of Care 45Magnetic Resonance Spectroscopy 45Cetuximab 44Capecitabine 44lenvatinib 43Radiosurgery 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Methylene Blue × 1 year × Clear all
NCT07040540 2026-04-30

Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General Anesthesia

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Completed
220 enrolled
Breast

Breast Neoplasms

NCT00314405 2025-12-22

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

University Hospital, Strasbourg, France

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡